Feasibility and Efficacy of Transvaginal Botulinum Toxin A Chemodenervation of the Bladder for the Third Line Treatment of Refractory Overactive Bladder
Latest Information Update: 26 Jul 2022
At a glance
- Drugs Botulinum-Toxin-A (Primary)
- Indications Overactive bladder
- Focus Therapeutic Use
- Acronyms FETOC
Most Recent Events
- 22 Jun 2022 New trial record
- 16 May 2022 Results presented at the 117th Annual Meeting of the American Urological Association